| Year |
Citation |
Score |
| 2022 |
Sahin U, de Thé H, Lallemand-Breitenbach V. Sumoylation in Physiology, Pathology and Therapy. Cells. 11. PMID 35269436 DOI: 10.3390/cells11050814 |
0.373 |
|
| 2022 |
Ergünay T, Ayhan Ö, Celen AB, Georgiadou P, Pekbilir E, Abaci YT, Yesildag D, Rettel M, Sobhiafshar U, Ogmen A, Emre NT, Sahin U. Sumoylation of Cas9 at lysine 848 regulates protein stability and DNA binding. Life Science Alliance. 5. PMID 35022246 DOI: 10.26508/lsa.202101078 |
0.611 |
|
| 2020 |
Celen AB, Sahin U. Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts. The Febs Journal. 287: 3110-3140. PMID 32255256 DOI: 10.1111/Febs.15319 |
0.613 |
|
| 2017 |
Maretzky T, Swendeman S, Mogollon E, Weskamp G, Sahin U, Reiss K, Blobel CP. Characterization of the Catalytic Properties of the Membrane-anchored Metalloprotease ADAM9 in Cell-based assays. The Biochemical Journal. PMID 28264989 DOI: 10.1042/Bcj20170075 |
0.571 |
|
| 2016 |
Sahin U, Jollivet F, Berthier C, de Thé H, Lallemand-Breitenbach V. Detection of Protein SUMOylation In Situ by Proximity Ligation Assays. Methods in Molecular Biology (Clifton, N.J.). 1475: 139-50. PMID 27631803 DOI: 10.1007/978-1-4939-6358-4_10 |
0.336 |
|
| 2015 |
Dassouki Z, Sahin U, El Hajj H, Jollivet F, Kfoury Y, Lallemand-Breitenbach V, Hermine O, de Thé H, Bazarbachi A. ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation. Blood. 125: 474-82. PMID 25395419 DOI: 10.1182/Blood-2014-04-572750 |
0.339 |
|
| 2015 |
Dassouki Z, Sahin U, El Hajj H, Jollivet F, Kfoury Y, Lallemand-Breitenbach V, Hermine O, de The H, Bazarbachi A. Tax as a therapeutic target in ATL Retrovirology. 12. DOI: 10.1186/1742-4690-12-S1-P57 |
0.347 |
|
| 2014 |
Sahin U, de Thé H, Lallemand-Breitenbach V. PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation. Nucleus (Austin, Tex.). 5: 499-507. PMID 25482067 DOI: 10.4161/19491034.2014.970104 |
0.356 |
|
| 2014 |
Sahin U, Lapaquette P, Andrieux A, Faure G, Dejean A. Sumoylation of human argonaute 2 at lysine-402 regulates its stability. Plos One. 9: e102957. PMID 25036361 DOI: 10.1371/Journal.Pone.0102957 |
0.393 |
|
| 2014 |
Sahin U, Ferhi O, Carnec X, Zamborlini A, Peres L, Jollivet F, Vitaliano-Prunier A, de Thé H, Lallemand-Breitenbach V. Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replication. Nature Communications. 5: 4187. PMID 24942926 DOI: 10.1038/Ncomms5187 |
0.405 |
|
| 2007 |
Sahin U, Blobel CP. Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17. Febs Letters. 581: 41-4. PMID 17169360 DOI: 10.1016/J.Febslet.2006.11.074 |
0.613 |
|
| 2006 |
Sahin U, Weskamp G, Zheng Y, Chesneau V, Horiuchi K, Blobel CP. A sensitive method to monitor ectodomain shedding of ligands of the epidermal growth factor receptor. Methods in Molecular Biology (Clifton, N.J.). 327: 99-113. PMID 16780215 DOI: 10.1385/1-59745-012-X:99 |
0.655 |
|
| 2004 |
Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. The Journal of Cell Biology. 164: 769-79. PMID 14993236 DOI: 10.1083/Jcb.200307137 |
0.601 |
|
| 2004 |
Zhou HM, Weskamp G, Chesneau V, Sahin U, Vortkamp A, Horiuchi K, Chiusaroli R, Hahn R, Wilkes D, Fisher P, Baron R, Manova K, Basson CT, Hempstead B, Blobel CP. Essential role for ADAM19 in cardiovascular morphogenesis. Molecular and Cellular Biology. 24: 96-104. PMID 14673146 DOI: 10.1128/Mcb.24.1.96-104.2004 |
0.511 |
|
| Show low-probability matches. |